IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease
The first infusion was delivered on December 29, 2020, by trial lead investigator Ricardo Knight, M.D., M.B.A. at the Company’s Brentwood, Tennessee facility....
The first infusion was delivered on December 29, 2020, by trial lead investigato...